1. A randomized controlled trial of a structured exercise intervention after the completion of acute cancer treatment in adolescents and young adults
- Author
-
Andrew Murnane, Michael Osborn, Cathy Pendergrast, Thomas Goddard, Morgan Atkinson, Rebecca Manudhane, and Paul Rogers
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Physical fitness ,Population ,FACIT Fatigue Scale ,law.invention ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Cancer Survivors ,Randomized controlled trial ,Quality of life ,law ,Neoplasms ,Survivorship curve ,Humans ,Medicine ,Young adult ,education ,education.field_of_study ,business.industry ,Cardiorespiratory fitness ,Hematology ,Prognosis ,Combined Modality Therapy ,humanities ,Exercise Therapy ,Survival Rate ,Oncology ,Case-Control Studies ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Quality of Life ,Physical therapy ,Female ,business ,Follow-Up Studies ,030215 immunology - Abstract
Background Cancer treatments are frequently associated with impaired physical fitness, quality of life (QOL), and fatigue, often persisting into survivorship. Studies in older adults with cancer have demonstrated benefits from exercise; however, this has not been rigorously investigated in adolescents and young adults (AYA). The aim of this study was to determine whether a structured 10-week exercise intervention was associated with improved cardiorespiratory fitness (VO2peak ), fatigue, and QOL in AYA who have recently completed cancer treatment. Method Forty-three AYA (median age 21 ± 6 years) were randomly assigned to an exercise group (n = 22) or a control group (n = 21). The exercise group received a structured 10-week exercise program comprising progressive aerobic and resistance exercise; the control arm received routine care. VO2peak was measured at baseline, 10 weeks, and six months. Fatigue and QOL were assessed by the FACIT fatigue scale and the PEDS QL, respectively. Results Mean VO2peak at baseline was 26.5 ± 7.2 mL.kg-1 .min-1 , which is substantially lower than population norms. The exercise group demonstrated significant improvement in VO2peak at 10 weeks compared with controls (33.8 ± 8.1 vs 29.6 ± 7.6 mL.kg-1 .min-1 , P = 0.0002), but by six months, the difference was no longer significant (32.9 ± 7.0 vs 30.9 ± 11.0 mL.kg-1 .min-1 , P = 0.21). There were no significant differences in fatigue or total QOL scores between groups. Conclusion Cancer treatment is associated with reduced VO2peak in AYA. Improvement in VO2peak was accelerated by a 10-week exercise program; however, no significant benefit was observed in QOL or fatigue. The plateau in VO2peak at six months suggests that a maintenance exercise program may be beneficial.
- Published
- 2020
- Full Text
- View/download PDF